Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs EPAM✓SelectedUSD · EPAMMRNA vs EPAM performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs EPAM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+948.4%
EPAM return
+19.8%
Excess return
+928.6%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioEPAMExcessAlpha
1D-2.2%+1.9%-4.0%-2.7%
7D-12.7%-6.1%-6.6%-11.2%
30D-20.7%+14.4%-35.0%-24.9%
3M+46.3%+43.5%+2.7%+29.1%
6M+305.2%+46.9%+258.3%+254.8%
YTD+561.2%-25.2%+586.4%+571.6%
1Y+772.1%-14.2%+786.3%+757.0%
3Y+147.0%-41.1%+188.1%+157.3%
5Y-26.1%-76.9%+50.8%-17.9%
All+948.4%+19.8%+928.6%+697.7%

Cumulative growth

Daily Returns

Daily percentage return beside EPAM.

Daily Out/Under-Performance

Portfolio return minus EPAM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × EPAM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded EPAM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling